Assessing the prevalence of neutralizing antibodies (NAbs) to SARS-CoV-2 during three years of the COVID-19 pandemic.
Saved in:
| Title: | Assessing the prevalence of neutralizing antibodies (NAbs) to SARS-CoV-2 during three years of the COVID-19 pandemic. |
|---|---|
| Authors: | Barreto MDS; Department of Pharmacy, Federal University of Sergipe, São Cristóvão, 49100-000, SE, Brazil., Santos RS; Department of Pharmacy, Federal University of Sergipe, São Cristóvão, 49100-000, SE, Brazil., Dias Silva EE; Department of Biology, Federal University of Sergipe, São Cristóvão, 49100-000, SE, Brazil., Rego Rodrigues Silva DM; Department of Pharmacy, Federal University of Sergipe, São Cristóvão, 49100-000, SE, Brazil., Macedo Moura PH; Department of Pharmacy, Federal University of Sergipe, São Cristóvão, 49100-000, SE, Brazil., de Jesus PC; Department of Pharmacy, Federal University of Sergipe, São Cristóvão, 49100-000, SE, Brazil., de Souza JB; Department of Pharmacy, Federal University of Sergipe, São Cristóvão, 49100-000, SE, Brazil., da Mota Santana LA; Graduate Program in Dentistry, Federal University of Sergipe, São Cristóvão, 49100-000, SE, Brazil., Guimarães AG; Department of Pharmacy, Federal University of Sergipe, São Cristóvão, 49100-000, SE, Brazil., Borges LP; Department of Pharmacy, Federal University of Sergipe, São Cristóvão, 49100-000, SE, Brazil.; Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, 05508-000, SP, Brazil. |
| Source: | Biochemistry and biophysics reports [Biochem Biophys Rep] 2024 Dec 17; Vol. 41, pp. 101903. Date of Electronic Publication: 2024 Dec 17 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101660999 Publication Model: eCollection Cited Medium: Internet ISSN: 2405-5808 (Electronic) Linking ISSN: 24055808 NLM ISO Abbreviation: Biochem Biophys Rep Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
